3-(CYCLOHEXYLAMINO)PROPANAMIDE
|
- $45 - $795.8
- Product name: 3-(CYCLOHEXYLAMINO)PROPANAMIDE
- CAS: 4552-48-1
- MF: C9H18N2O
- MW: 170.25
- EINECS:
- MDL Number:MFCD01475860
- Synonyms:3-(CYCLOHEXYLAMINO)PROPANAMIDE;N3-cyclohexyl-b-alaninamide;Propanamide, 3-(cyclohexylamino)-;N3-Cyclohexyl-β-alaninamide
5 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Aronis compounds
- Matrix Scientific
- TRC
Package
- 10mg
- 500MG
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0085418
- Product description3-(CYCLOHEXYLAMINO)PROPANAMIDE 95.00%
- Packaging500MG
- Price$795.8
- Updated2021-12-16
- Buy
- ManufacturerAronis compounds
- Product numberBBB/918
- Product descriptionN3-cyclohexyl-b-alaninamide
- Packaging1g
- Price$173
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number026874
- Product description3-(Cyclohexylamino)propanamide
- Packaging500mg
- Price$199
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number026874
- Product description3-(Cyclohexylamino)propanamide
- Packaging1g
- Price$306
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberA620175
- Product descriptionN3-Cyclohexyl-β-alaninamide
- Packaging10mg
- Price$45
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM0085418 | 3-(CYCLOHEXYLAMINO)PROPANAMIDE 95.00% | 500MG | $795.8 | 2021-12-16 | Buy |
| Aronis compounds | BBB/918 | N3-cyclohexyl-b-alaninamide | 1g | $173 | 2021-12-16 | Buy |
| Matrix Scientific | 026874 | 3-(Cyclohexylamino)propanamide | 500mg | $199 | 2021-12-16 | Buy |
| Matrix Scientific | 026874 | 3-(Cyclohexylamino)propanamide | 1g | $306 | 2021-12-16 | Buy |
| TRC | A620175 | N3-Cyclohexyl-β-alaninamide | 10mg | $45 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|